Technology Title
Sunt non laborum ips
Sunt non laborum ips
Project Title
Development of a Novel Gene Editing Tool for Cancer Treatment
Development of a Novel Gene Editing Tool for Cancer Treatment
Category
Patented
Patented
Short Description
A gene editing tool that uses CRISPR-Cas9 technology to selectively kill cancer cells
A gene editing tool that uses CRISPR-Cas9 technology to selectively kill cancer cells
Long Description
This project involves the development of a novel gene editing tool that uses CRISPR-Cas9 technology to selectively kill cancer cells. The tool is designed to target specific genes that are involved in cancer cell growth and proliferation, and to deliver a lethal dose of a chemotherapeutic agent to the cancer cells. The project has shown promising results in preclinical studies, and is currently in the process of being translated to the clinic.
This project involves the development of a novel gene editing tool that uses CRISPR-Cas9 technology to selectively kill cancer cells. The tool is designed to target specific genes that are involved in cancer cell growth and proliferation, and to deliver a lethal dose of a chemotherapeutic agent to the cancer cells. The project has shown promising results in preclinical studies, and is currently in the process of being translated to the clinic.
Potential Applications
Cancer treatment, gene therapy, personalized medicine
Cancer treatment, gene therapy, personalized medicine
Image
Tags
First Choice, Second Choice, Third Choice
First Choice, Second Choice, Third Choice
Email
main@mailinator.com
main@mailinator.com